利用纳米粒子重塑瘤免疫微环境的肝细胞癌
JinSong Li1, GuanBo Zhang1, Gang Li1
1Department of Hepatobiliary Vascular Surgery, Chengdu Seventh People's Hospital, Chengdu, 610041, Sichuan, China.
Discover oncology
|February 5, 2025
概括
免疫疗法对肝细胞癌 (HCC) 有希望,但面临阻力. 纳米粒子提供了一种新的策略,通过向HCC中的瘤微环境 (TIME) 来增强免疫疗法.
科学领域:
- 在瘤学瘤学.
- 免疫学 免疫学 免疫学
- 纳米技术纳米技术
背景情况:
- 肝细胞癌 (HCC) 由于高发病率和死亡率,给全球健康带来了重大挑战.
- 免疫疗法是HCC的重要治疗方法,但临床成功受到获得的耐药性和瘤免疫抑制微环境 (TIME) 的限制.
研究的目的:
- 在HCC中审查TIME的原则.
- 讨论纳米技术在克服HCC免疫疗法耐药性的应用.
- 探索纳米医学在HCC治疗中的挑战和机遇.
主要方法:
- 关于HCC,免疫疗法,TIME和纳米技术的当前文献的审查.
- 分析基于纳米粒子的增强HCC免疫疗法的策略.
- 对纳米药物的临床翻译挑战的讨论.
主要成果:
- 纳米颗粒可以通过向HCC组织和调节时间来提高免疫疗法的有效性.
- 通过纳米颗粒向提供免疫治疗药物可以克服抵抗机制.
- 了解纳米生物相互作用是开发有效纳米药物的关键.
结论:
- 纳米技术具有显著的潜力,可以改善HCC患者的免疫治疗结果.
- 通过纳米医学克服与 TIME 相关的耐药性是一种有前途的治疗途径.
- 需要进一步的研究和临床转化来实现纳米药物在HCC治疗中的全部潜力.
相关概念视频
Tumor Immunotherapy
464
Immunotherapy is a treatment that boosts or manipulates the immune system to fight diseases, including cancer. For instance, by stimulating an immune response through vaccinations against viruses that cause cancers, like hepatitis B virus and human papillomavirus, these diseases can be prevented. Nonetheless, some cancer cells can avoid the immune system due to their rapid mutation and division. The immune response to many cancers involves three phases: elimination, equilibrium, and escape.
464
The Tumor Microenvironment
6.5K
Every normal cell or tissue is embedded in a complex local environment called stroma, consisting of different cell types, a basal membrane, and blood vessels. As normal cells mutate and develop into cancer cells, their local environment also changes to allow cancer progression. The tumor microenvironment (TME) consists of a complex cellular matrix of stromal cells and the developing tumor. The cross-talk between cancer cells and surrounding stromal cells is critical to disrupt normal tissue...
6.5K


